WINNIPEG, MB--(Marketwired - January 23, 2015) - On Thursday, January 29, 2015, the Multiple Sclerosis Society of Canada and the Multiple Sclerosis Scientific Research Foundation, along with principal investigators Dr. Mark Freedman and Dr. James Marriott, will be announcing a human clinical trial involving a novel stem cell treatment in multiple sclerosis (MS).
Canada has the highest rate of MS in the world. MS is a chronic, often disabling disease of the central nervous system comprising the brain, spinal cord and optic nerve. It is one of the most common neurological diseases affecting young adults in Canada. Most people with MS are diagnosed between the ages of 15 and 40, and the unpredictable effects of MS last for the rest of their lives.
Media are welcome to attend an event at Health Sciences Centre Winnipeg where Mr. Yves Savoie, president and CEO of the MS Society of Canada, and Dr. James Marriott will announce the details of this landmark study.
When: 12pm CT, Thursday, January 29, 2015
Interview and photo opportunities will be available with:
- Mr. Yves Savoie, President and CEO, MS Society of Canada
- Dr. Karen Lee, Vice President, Research, MS Society of Canada
- Dr. James Marriott, principal investigator
- Dr. Mark Freedman, principal investigator, will be available for interviews via telephone
- Miss Lizelle Mendoza, Winnipeg resident living with MS
Where: Courtyard Café, Health Sciences Centre Winnipeg
Magenta Fox Zone, Level 2
800 Sherbrook St.
Winnipeg, Manitoba
Note: The Courtyard Café is located on the 2nd floor of the Rehabilitation Centre at Health Sciences Centre Winnipeg.
Join the conversation and connect with the MS community online. Find the MS Society on Twitter, Instagram or like our page on Facebook.
Contact Information:
For more information and to confirm attendance at the media event, please contact:
Lindsay Gulin
MS Society of Canada
1-800-268-7582 ext. 3245
lindsay.gulin@mssociety.ca